LIst of Database in the Warehouse
The list of database available in the warehouse for our members is listed below. Click on the Study Unique Identifier (SUI) to access to a brief description of this data.
The number of ECGs available in each study is provided in the column labelled ECGs. The column entitled Ind. contains the number of individuals/patients available in each database.
| Study | ECGs | Ind. | SUI |
|---|---|---|---|
Thorough QT Study #1 (Including a unknown Compound with positive QT/QTc signal) |
175 |
34 |
|
Coronary Artery Patients |
273 |
273 |
|
Acute Myocardial Infarction Patients |
140 |
140 |
|
Sotalol data |
Up coming | ||
Thorough QT study #2 |
Available January 2009 | ||
Holter with drug-induced TdPs |
Up coming | ||
Holter with TdPs (inherited LQTS) |
Up Coming | ||
Individuals with history of drug-induced TdPs |
Up coming | ||
Healthy individuals |
206 |
206 |
[11/01/2008] Striving to advance the field of cardiac safety, the THEW initiative is developed for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, University of Rochester (UR), and other public and private stakeholders. The THEW is led by individuals from the UR, the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More...
[05/27/2008] Dr. Janet Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Acting Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...